Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluzone High-Dose vs Standard Dose in Healthcare Workers
NCT02263040Phase 2Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Oct 2014
- Primary completion
- Jul 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of influenza virus vaccine, split virion in influenza (2 arms), sponsored by Mount Sinai Hospital. Primary endpoints: Number of Participants With Seroconversion to A/California/07/2009 (H1N1) at 21 days, Number of Participants With Seroconversion to A/Texas/50/2012 (H3N2) at 21 days and 3 more. Started Oct 2014; status: completed.
02
Drugs
influenza virus vaccine, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02263040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02263040.